Table 4.

Active imatinib/combination phase III randomized studies

Study site randomization
Germany/Switzerland Imatinib ± interferon alfa or cytarabine vs interferon followed by stem cell transplant
France Imatinib 400 mg vs imatinib 400 mg + cytarabine vs imatinib 400 mg + peginterferon alfa-2a vs imatinib 600 mg
Austria Imatinib 800 mg followed by imatinib 400 mg compared with a continuous treatment with imatinib 400 mg
Israel Imatinib vs imatinib and peginterferon after complete cytogenetic response with imatinib therapy
USA/UK Nilotinib 300 mg vs 400 mg twice daily vs imatinib 400 mg
Multinational Dasatinib vs imatinib
Multinational Bosutinib vs imatinib